TABLE 1.
Characteristic | Total patients | COVID‐19 outpatients | COVID‐19 with fever | COVID‐19 with emergencies | p‐Value a |
---|---|---|---|---|---|
No. (%) | 663 | 420 (63.4) | 171 (25.8) | 72 (10.9) | |
Distribution, n (%) | |||||
March | 112 (16.9%) | 94 (22.4%) | 18 (10.5%) | 0 (0) | |
April | 465 (70.1%) | 297 (70.7%) | 108 (63.2%) | 60 (83.3%) | |
May | 86 (13.0%) | 29 (6.9%) | 45 (26.3%) | 12 (16.7%) | |
Sex, n (%) | |||||
Male | 403 (60.8%) | 296 (70.5%) | 75 (43.9%) | 32 (44.4%) | <0.001 |
Female | 260 (39.2%) | 124 (29.5%) | 96 (56.1%) | 40 (55.6%) | |
Age, year | 45 (31–62) | 40 (30–52) | 59 (37–71) | 66 (48–75) | <0.001 |
Age groups, n (%) | |||||
<18 years | 10 (1.5%) | 3 (0.7%) | 6 (3.5%) | 1 (1.4%) | |
18–49 years | 363 (54.8%) | 291(69.3%) | 54 (31.6%) | 18 (25.0%) | |
50–79 years | 248 (37.4%) | 121 (28.8%) | 89 (52.0%) | 38 (52.8%) | |
≥80 years | 42 (6.3%) | 5 (1.2%) | 22 (12.9%) | 15 (20.8%) | |
RT‐PCR Ct value | |||||
ORF1ab gene | 27.4 (23.1–32.1) | 28.3 (23.5–32.7) | 25.5 (22.4–29.4) | 27.5 (23.2–32.8) | <0.001 |
N gene | 26.3 (21.8–32.2) | 27.7 (22.5–33.1) | 24.0 (20.6–29.2) | 26.3 (22.1–32.9) | <0.001 |
Comparison of three subgroups. Data are shown as number (%) or median (interquartile range). RT‐PCR, reverse transcription polymerase chain reaction; Ct, cycle threshold.